I'm not sure if Phred Garvin had planned to post this here

New Post Public Reply Private Reply Replies (3) Message Board
nk65 CashStrapped #2464
I'm not sure if Phred Garvin had planned to post this here today but he is knocking it out of the park with his DD. He wrote the following -

" PPS $EWSI is massively undervalued.

I don't feel the need to post very often, but we’re due for a re-write on how EWSI trades vs. other OTC stocks, as well as take look at some 2014 projections. If you are investing, you should learn all you can about the company and read the EDGAR/SEC filings rather than rely on the opinions of those on a message board, my opinion included.

Information is KING in my book. I have done some simple due diligence by pulling out numbers from prior financial and making some mathematical implications. Real Information. The numbers will be audited, and they will come out on time. Read all the K's from last year, and all the statements from the CEO. Some like to bash the accountant, or the change of accountants or something of the like, but the reality is that this is a real company and they are filing numbers through the SEC in a timely manner.

This stock should shake loose of all the games and start to actually trade logically. I guess putting logic out instead of fear and disinformation might be helpful to potential investors.

I've been to EWSI facilities. I know Martie. Martie is ALL about measurables, which is why he continues to hit his goals as EWSI picks up its stride. There are those that like to give him a daily bash, but he's a good guy, and he has yet to sell any shares. You can feel free to look it up at EDGAR. All verifiable. http://www.nasdaq.com/symbol/ewsi/insider-trades/sells In fact NO insider has sold yet.

I'm excited for Malone Bailey, as they have way better experience truing up Chinese accounting with GAAP. This is an area of expertise that Sadler was lacking, and Martie corrected the deficiency. Give Martie his props here. Good foresight as China is expanding fast, and it appears all the major accounting companies are challenged in the nuances of Chinese accounting.

IMO after reading all the K's, the re-audited 2Q and 3Q numbers are going to be BETTER than previously reported. There seems to be a $750,000 swing in EWSI favor. Look it up. It’s all in there.

There is SO much good news with $EWSI as Martie keeps hitting his numbers. PPS logically has to catch up, and it may happen explosively. A major point of the otherwise lackluster conference call was the corporate wide push to uplist.

Clearly Martie wants to escape the games of the OTC. When we hit $60m market value, $2+ a share and over 300 shareholders, we're Nasdaq bound IMO!

Its time to again revisit basic math on $EWSI. The longs know what they hold, and here's why we toss out the emotional games and look at the numbers.

Based on 250M shares.

Lets make some logical assumptions for Q4 and annualized 2014 numbers. Once Malone Bailey audits, my guess is that we have a revised Q3 adding $750K ($2,076,130 from PRODUCT sales & $3,254,310 from SERVICE revenues + wherever the $750K falls), pushing the pre Q4 (Q1+Q2+Q3) number from 8.429M to 9.179M.

Let’s put Q4 at around 10M with the addition of 2TRG numbers. That puts our annual revenue at an estimated $19.179M.
Awesome growth, and Martie has stated that he will continue to focus on his growth as a priority for 2014. Feel free to scale the Q4 up and down based on your own DD.

The next thing we have to discuss is a multiplier value. I’ve used all sorts of econometric modeling to test out different theories, but a good back of the envelope Market Cap multiplier should be about 5+ times a company's annual revenue. This multiplier adjusts up or down for profitability, growth, assets and other variables, but it is a good back of the envelope estimator. Feel free to use your own. I modeled everything from 2.25 to 7.75.

Q4: $10 mm
9.179 + 10 = $19.179 mm , making market cap 5x19.179=$95.895 Market Cap
@ 250,000,000 = $.38 PPS

So right now we not only have a PPS BELOW the annualized revenue, but we are trading substantially below a completely reasonable PPS estimate.

Lets roll into 2014 Numbers, and use Martie’s words on projections, and while doubling of Q’s has to slow down at some point, it will mostly hold in 2014 due to strong M&A, which is the core of the business expansion model. You can play with this as well, but thus far, one must take Martie at his word on his business plan for 2014.

At this point we should talk dilution and move the O/S to 300M. You can play with this number as well. As long as growth continues, I’m comfortable with controlled dilution. Got to keep enough shares in the middle for new investors to get in, as the float will get locked as insiders aren’t selling, and there has been a lot of accumulation into long hands. Lots of flippers get hung up on dilution, and there's been a huge amount speculated on this, but proper dilution helps spread out the stock to new investors, and the pool will have to increase if EWSI is going to uplist. It is a Nasdaq requirement. 300+ individual shareholders. These are my estimates and you can scale them at will.

Q4 -13 ~10M

Q1 -14 ~15M
Q2 -14 ~25M
Q3 -14 ~40M
Q4 -14 ~65M
2014 TOTAL: $145M

Market cap: depends on multiplier.
At 2.25 = $326M or $1.08 PPS @ 300M Shares
At 5.0 = $725M or $2.41 PPS @ 300M Shares

Feel free to mod the math with your own projections. Do your own DD on this one. It is my only OTC stock that I trade, as it operates with the clarity and filing of a big board company. The CEO actively pursues the goals and transparency of a Nasdaq company.

While there are constant games with the stock of the company, separating that out there is little doubt that the core of the company is a well managed company that is doing what 99.99% of companies on the OTC cannot. It posts auditable revenues and is breaking ground in a previously untapped market for a public company"

E-Waste Systems, Inc. (EWSI) Stock Research Links

EWSI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading